Oklahoma’s new cancer screening requirement isn’t as transparent for patients as it should be

Yet the law does not always tell a patient what will happen when they hand over their insurance card. That means some Oklahomans may still be billed for care they thought the new law covered, while others may not know whether their scan or genetic test qualifies until after the appointment.

The specific promises within HB 1389 are that if a patient needs additional breast cancer imaging because a standard mammogram may not be enough, insurance should cover those exams. SB 109, on the other hand, requires certain health plans to cover inherited cancer genetic testing and evidence-based cancer imaging for people with increased cancer risk because of personal or family history. In fact, SB 109 is written as coverage without deductibles, copays, or coinsurance.

But the promises become more complicated once someone enters the insurance system.

The first complication is that not every insurance plan is controlled by state law; many employers use self-funded health plans. These plans allow the employer to pay claims while an insurance company administers the plan and are generally regulated by federal law, not state mandates. In essence, a patient can live in Oklahoma, hear that Oklahoma passed a cancer coverage law, and still be enrolled in a plan the law may not reach.

Then comes the issue of cost-sharing. Some high-deductible health plans may still require patients to meet a deductible first unless the service is considered preventive. This distinction is hard to pinpoint. For instance, a routine mammogram for someone without symptoms is generally treated as preventive screening. A mammogram or ultrasound ordered after a lump, symptom, or abnormal result is generally diagnostic.

A supplemental examination is different. It may be ordered because a patient has dense breast tissue or elevated cancer risk even when no cancer has been found. To the patient, all three can feel like early detection. To an insurer, they may be processed differently. In addition, high-deductible plans tied to Health Savings Accounts operate under federal tax rules that generally limit what can be covered before a deductible is met.

These exceptions have led to recent reports from KFOR that some Oklahoma women have received bills for scans they believe state law was supposed to cover. In that report, Insurance Commissioner Glen Mulready pointed to the major limitation of state insurance mandates: self-funded employer plans are not required to follow state law. KFOR reported that those plans cover about 60% of Oklahomans.

That means a large share of Oklahomans may be outside the automatic protection lawmakers created. The issue that the Oklahoma Legislature attempted to solve therefore persists: early detection methods and technology exist in Oklahoma, but patients cannot always know whether they can afford to use them before care is delivered

A practical solution could be making protections more obvious and easier to understand before care is delivered.

A plain-language guide could help patients ask whether their plan is state-regulated or self-funded and whether their test is considered screening, diagnostic, or supplemental. Clearer notices from insurers and providers could also help patients understand when the law does not apply. Insurers and providers could also offer a simple “what now?” pathway for patients who receive an unexpected bill, including how to ask about plan type, billing codes, appeals, and complaints.

Oklahoma’s cancer coverage laws are meaningful, but state mandates alone cannot protect every patient. That makes transparency and enforcement even more important, because patients need to know whether the law applies before they schedule care.

SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX.

SUPPORT: YOU MAKE OUR WORK POSSIBLE